TY - JOUR
T1 - Survival Benefit of Additional Surgery After Non-curative Endoscopic Submucosal Dissection for Early Gastric Cancer
T2 - A Propensity Score Matching Analysis
AU - Suzuki, Sho
AU - Gotoda, Takuji
AU - Hatta, Waku
AU - Oyama, Tsuneo
AU - Kawata, Noboru
AU - Takahashi, Akiko
AU - Yoshifuku, Yoshikazu
AU - Hoteya, Shu
AU - Nakagawa, Masahiro
AU - Hirano, Masaaki
AU - Esaki, Mitsuru
AU - Matsuda, Mitsuru
AU - Ohnita, Ken
AU - Yamanouchi, Kohei
AU - Yoshida, Motoyuki
AU - Dohi, Osamu
AU - Takada, Jun
AU - Tanaka, Keiko
AU - Yamada, Shinya
AU - Tsuji, Tsuyotoshi
AU - Ito, Hirotaka
AU - Hayashi, Yoshiaki
AU - Shimosegawa, Tooru
N1 - Publisher Copyright:
© 2017, Society of Surgical Oncology.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Background and Purpose: Previous studies comparing survival outcomes between patients who did and did not undergo additional surgery after non-curative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) were limited in that the baseline characteristics differed significantly between the groups. We aimed to address this limitation and compared survival outcomes between these two groups using propensity score matching analysis. Methods: The study enrolled 1969 consecutive patients who underwent non-curative ESD for EGC between 2000 and 2011 at any of 19 institutions across Japan. Using propensity score matching analysis, patients who underwent additional surgery (n = 1064) were compared with patients who did not (n = 905). Overall survival (OS) and disease-specific survival (DSS) after ESD were compared between both groups. Results: Propensity score matching analysis yielded 553 matched pairs and well-balanced baseline characteristics between the two groups. The 5-year OS rates were 91.0% in the additional surgery group and 75.5% in the no additional surgery group, and the 5-year DSS rates were 99.0 and 96.8%, respectively. OS and DSS in the additional surgery group were significantly higher than in the no additional surgery group (OS, p < 0.001; DSS, p = 0.013). In Cox proportional hazard analysis, additional surgery significantly reduced gastric cancer-related death after non-curative ESD for EGC (hazard ratio 0.33, 95% confidence interval 0.12–0.79, p = 0.012). Conclusions: Our findings suggest that additional surgery reduces mortality after non-curative ESD for EGC. We recommend additional surgery for patients after non-curative ESD for EGC.
AB - Background and Purpose: Previous studies comparing survival outcomes between patients who did and did not undergo additional surgery after non-curative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) were limited in that the baseline characteristics differed significantly between the groups. We aimed to address this limitation and compared survival outcomes between these two groups using propensity score matching analysis. Methods: The study enrolled 1969 consecutive patients who underwent non-curative ESD for EGC between 2000 and 2011 at any of 19 institutions across Japan. Using propensity score matching analysis, patients who underwent additional surgery (n = 1064) were compared with patients who did not (n = 905). Overall survival (OS) and disease-specific survival (DSS) after ESD were compared between both groups. Results: Propensity score matching analysis yielded 553 matched pairs and well-balanced baseline characteristics between the two groups. The 5-year OS rates were 91.0% in the additional surgery group and 75.5% in the no additional surgery group, and the 5-year DSS rates were 99.0 and 96.8%, respectively. OS and DSS in the additional surgery group were significantly higher than in the no additional surgery group (OS, p < 0.001; DSS, p = 0.013). In Cox proportional hazard analysis, additional surgery significantly reduced gastric cancer-related death after non-curative ESD for EGC (hazard ratio 0.33, 95% confidence interval 0.12–0.79, p = 0.012). Conclusions: Our findings suggest that additional surgery reduces mortality after non-curative ESD for EGC. We recommend additional surgery for patients after non-curative ESD for EGC.
UR - http://www.scopus.com/inward/record.url?scp=85027144131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027144131&partnerID=8YFLogxK
U2 - 10.1245/s10434-017-6039-4
DO - 10.1245/s10434-017-6039-4
M3 - Article
C2 - 28795364
AN - SCOPUS:85027144131
SN - 1068-9265
VL - 24
SP - 3353
EP - 3360
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 11
ER -